Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 2, 2011, Pages 356-362

  Georg, Petra ^a   Lang, Stefan ^a   Dimopoulos, Johannes C A ^a   Dörr, Wolfgang ^a,b   Sturdza, Alina E ^a   Berger, Daniel ^a   Georg, Dietmar ^a   Kirisits, Christian ^a   Pötter, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cervical cancer; Dose volume histogram; Image guided brachytherapy; Organs at risk; Side effects

Indexed keywords

BRACHYTHERAPY; CERVICAL CANCERS; DOSE-VOLUME HISTOGRAM; ORGANS AT RISKS; SIDE EFFECT;

CHEMOTHERAPY; GRAPHIC METHODS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONSTIPATION; CYSTITIS; DIARRHEA; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEMATURIA; HISTOGRAM; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RECTUM HEMORRHAGE; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COLON, SIGMOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ORGANS AT RISK; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM; TUMOR BURDEN; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 78650814979     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.11.002     Document Type: Article

References (45)

1. C. Haie-Meder, R. Pötter, and E. van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2004 235 245
2. R. Pötter, C. Haie-Meder, and E. van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
3. J.C.A. Dimopoulos, S. Lang, and C. Kirisits Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 75 2009 56 63
4. R. Pötter, J. Dimopoulos, and B. Bachtiary 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up Radiother Oncol 79 2006 80 86
5. R. Pötter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
6. J.C. Dimopoulos, C. Kirisits, and P. Petric The Vienna applicator for combined intracavitary and interstitial barchytherapy of cervical cancer: Clinical feasibility and preliminary results Int J Radiat Oncol Biol Phys 66 2006 83 90
7. A.N. Viswanathan, J. Dimopoulos, and C. Kirisits Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498
8. M. De Brabandere, A.G. Mousa, and A. Nulens Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma Radiother Oncol 88 2008 217 226
9. J.C. Lindegaard, K. Tanderup, and S.K. Nielsen MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 71 2008 756 764
10. C. Chargari, N. Magne, and I. Dumas Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 133 139
11. D. Zwahlen, J. Jezioranski, and P. Chan Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix Int J Radiat Oncol Biol Phys 74 2009 1157 1164
12. L.T. Tan, C.E. Coles, and C. Hart Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience Clin Oncol (R Coll Radiol) 21 2009 175 182
13. C.A. Perez, S. Breaux, and J.M. Bedwinek Radiation therapy alone in the treatment of carcinoma of the uterine cervix II. Analysis of complications Cancer 54 1984 235 246
14. I. Barillot, J. Horiot, and P. Maingon Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies Int J Radiat Oncol Biol Phys 48 2000 189 200
15. C.A. Perez, P.W. Grigsby, and M.A. Lockett Radiation morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation Int J Radiat Oncol Biol Phys 44 1999 855 866
16. B.G. Clark, L. Souhami, and T.N. Roman The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 38 1997 989 993
17. S.W. Chen, J.A. Liang, and S.N. Yang The prediction of late rectal complication following the treatment of the uterine cervical cancer by high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 955 961
18. W.S. Koom, D.Y. Sohn, and J.Y. Kim Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy Int J Radiat Oncol Biol Phys 68 2007 1446 1454
19. P. Georg, C. Kirisits, and G. Goldner Correlation of dose volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI based brachytherapy Radiother Oncol 91 2009 173 180
20. C. Kirisits, S. Lang, and J. Dimopoulos The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning and dosimetric results Int J Radiat Oncol Biol Phys 65 2006 624 630
21. S. Lang, C. Kirisits, and J. Dimopoulos Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints Int J Radiat Oncol Biol Phys 69 2007 619 627
22. J.C.A. Dimopoulos, G. Schard, and D. Berger Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk Int J Radiat Oncol Biol Phys 64 2006 1380 1388
23. C. Kirisits, R. Pötter, and S. Lang Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911
24. International Commission of Radiation Units and Measurements Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU report 38 1985 ICRU Bethesda, MD
25. LENT SOMA tables Int J Radiat Oncol Biol Phys 31 1995 1048 1092
26. J.J. Pavy, J. Denekamp, and J. Letschert EORTC Late Effects Working Group. Late effects toxicity scoring: The SOMA scale Radiother Oncol 35 1995 11 15
27. P. Rubin, L.S. Constine, and L. Fajardo Overview: Late effects of normal tissue (LENT) scoring system Int J Radiat Oncol Biol Phys 31 1995 1041 1042
28. J.A. Routledge, M.P. Burns, and R. Swindell Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma Int J Radiat Oncol Biol Phys 56 2003 502 510
29. S.E. Davidson, M.P. Burns, and J.A. Routledge Assessment of morbidity in carcinoma of the cervix: A comparison of the LENT SOMA scales and Franco-Italian glossary Radiother Oncol 69 2003 195 200
30. D.D. Deshpande, S.K. Shrivastav, and A.S. Pradhan Dosimetry of intracavitary applications in carcinoma of the cervix: Rectal dose analysis Radiother Oncol 42 1997 163 166
31. C.E. Pelloski, M. Palmer, and G.M. Chronowski Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 131 137
32. N. Wachter-Gerstner, S. Wachter, and E. Reinstadler Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point Radiother Oncol 68 2003 269 276
33. D. Pedersen, S.M. Bentzen, and J. Overgaard Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 29 1994 941 952
34. A.E. Sturdza, D. Berger, and S. Lang Uncertainties in assessing sigmoid dose volume parameters in MRI-guided fractionated HDR brachytherapy Brachytherapy 7 2008 109
35. R. Pötter, C. Kirisits, and E.F. Fidarova Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma Acta Oncol 47 2008 1325 1336
36. R. Pötter, E. Van Limbergen, and N. Gerstner Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy Radiother Oncol 58 2001 11 17
37. C. Orton, and S. Rosenblum Dose dependence of complication rates in cervix cancer radiotherapy Int J Radiat Oncol Biol Phys 12 1986 37 44
38. H. Pourquier, R. Delard, and E. Achiulle A quantified approach of the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix Int J Radiat Oncol Biol Phys 13 1987 1025 1033
39. G. Sinistrero, P. Sismondi, and A. Rumore Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary Int J Radiat Oncol Biol Phys 26 1993 203 211
40. G.S. Montana, and W.C. Fowler Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications Int J Radiat Oncol Biol Phys 16 1989 95 100
41. H.J. Kim, S. Kim, and S.W. Ha Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer? Tumori 94 2008 327 332
42. T.J. Kuipers, and A.G. Visser Technical aspects of bladder dosimetry in intracavitary irradiation of cervix carcinoma Radiother Oncol 7 1987 7 12
43. L.T. Tan, J. Warren, and G. Freestone Bladder dose estimation during intracavitary brachytherapy for carcinoma of the cervix using a single line source system Br J Radiol 69 1996 953 962
44. I. Barillot, J.C. Horiot, and P. Maingon Maximum and mean bladder dose defined from ultrasonography: Comparison with the ICRU reference in gynaecological brachytherapy Radiother Oncol 30 1994 231 238
45. K.S. Kapp, G.F. Stuecklschweiger, and D.S. Kapp Dosimetry of intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD and CT assisted techniques Radiother Oncol 24 1992 137 146